Recently Featured

SLAS Highlights: Opening Keynote Spotlights Novel Target in Genomically Unstable Tumors

February 20, 2026
BOSTON—The recent SLAS conference in Boston showcased a pivotal keynote by Dr. Serena Silver, chief scientific officer of Accent Therapeutics, emphasizing the KIF18A protein as a promising target for precision oncology. This focus aligns with the increasing integration of automation in drug discovery and bioprocessing, underscoring the industry’s shift towards high-throughput methodologies. Dr. Silver’s insights…

Mexico enlists Moderna to boost mRNA supply for respiratory diseases

February 20, 2026
Mexico has officially partnered with Moderna to enhance its supply of mRNA vaccines aimed at combating respiratory diseases. This strategic collaboration marks a significant step for the country, which has historically lagged behind the United States in mRNA technology adoption. By leveraging Moderna’s advanced portfolio, Mexico aims to strengthen its public health response, particularly in…

FDA Warns Against Boner Bears Chocolate Bars Due to Hidden Drug Ingredient

February 20, 2026
The Food and Drug Administration (FDA) has issued a warning regarding Boner Bears Chocolate Bars, a product marketed for sexual enhancement that may contain undisclosed pharmaceutical ingredients. This advisory highlights concerns over the safety and efficacy of the product, which is available on various online platforms, including elyxr.com, and potentially in physical retail locations. This…

Stop Searching, Start Connecting: Your Global API & FDF Hub

February 20, 2026
If you’ve been in the pharma business for a while, you know that finding a reliable supplier is often a mess of outdated websites and dead-end contacts. Global API & FDF Hub (api-fdf.com) has been around for over 10 years, serving as a straightforward tool for those who need accurate data without the noise. Here…

Ongoing Cases